BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3367537)

  • 1. Measurement of inositol in uremic serum by selected ion monitoring.
    Inouye M; Mio T; Sumino K
    Jpn J Med; 1988 Feb; 27(1):29-33. PubMed ID: 3367537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of myo-inositol in diabetic sera by GC/MS/SIM using n-butylboronate derivatives.
    Hasegawa M; Doi K; Baba S
    Clin Chim Acta; 1988 Aug; 176(2):207-12. PubMed ID: 3180469
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantification of serum 1,5-anhydroglucitol in uremic and diabetic patients by liquid chromatography/mass spectrometry.
    Niwa T; Dewald L; Sone J; Miyazaki T; Kajita M
    Clin Chem; 1994 Feb; 40(2):260-4. PubMed ID: 8313603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myo-inositol clearance in renal failure and in patients with normal kidney function.
    Melmed S; Lewin LM; Bank H
    Am J Med Sci; 1977; 274(1):55-9. PubMed ID: 900156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of some abnormal metabolites in plasma from uremic subjects.
    Bultitude FW; Newham SJ
    Clin Chem; 1975 Aug; 21(9):1329-34. PubMed ID: 1149237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selected ion monitoring of metoprolol and two metabolites in plasma and urine using deuterated internal standards.
    Ervik M; Hoffmann KJ; Kylberg-Hanssen K
    Biomed Mass Spectrom; 1981 Jul; 8(7):322-6. PubMed ID: 7284572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gas chromatographic--mass spectrometric analysis of polyols in urine and serum of uremic patients. Identification of new deoxyalditols and inositol isomers.
    Niwa T; Yamamoto N; Maeda K; Yamada K; Ohki T; Mori M
    J Chromatogr; 1983 Oct; 277():25-39. PubMed ID: 6643610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of quinolinic acid in uremic serum and its removal by hemodialysis.
    Niwa T; Yoshizumi H; Emoto Y; Miyazaki T; Hashimoto N; Takeda N; Tatematsu A; Maeda K
    Clin Chem; 1991 Feb; 37(2):159-61. PubMed ID: 1825184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myoinositol--a uremic neurotoxin?
    Blumberg A; Esslen E; Bürgi W
    Nephron; 1978; 21(4):186-91. PubMed ID: 683404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serum polyol pattern and the urinary polyol excretion in diabetic and in uremic patients.
    Pitkänen E
    Clin Chim Acta; 1972 Apr; 38(1):221-30. PubMed ID: 5031782
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid analysis of sorbitol, galactitol, mannitol and myoinositol mixtures from biological sources.
    Eades DM; Williamson JR; Sherman WR
    J Chromatogr; 1989 May; 490(1):1-8. PubMed ID: 2503529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of veralipride in plasma and urine by gas chromatography-mass spectrometry and gas chromatography with flame-ionization detection.
    Staveris S; Jung L; Jamet G; Koffel JC
    J Chromatogr; 1985 Feb; 338(1):79-88. PubMed ID: 4019658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gas chromatographic mass spectrometric determination of myo-inositol in humans utilizing a deuterated internal standard.
    Andersen JR; Larsen E; Harbo H; Bertelsen B; Christensen JE; Gregersen G
    Biomed Mass Spectrom; 1982 Apr; 9(4):135-40. PubMed ID: 7046826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raised plasma-myoinositol levels in uraemia and experimental neuropathy.
    Clements RS; DeJesus PV; Winegrad AI
    Lancet; 1973 May; 1(7813):1137-41. PubMed ID: 4123536
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum.
    Powell DR; Rosenfeld RG; Baker BK; Liu F; Hintz RL
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1186-92. PubMed ID: 3760118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling of uremic ultrafiltrate using high resolution gas chromatography-mass spectrometry - identification of 6 polyphenols.
    Niwa T; Maeda K; Ohki T; Saito A; Kobayashi S; Asada H; Kobayashi K
    Clin Chim Acta; 1980 Nov; 108(1):113-9. PubMed ID: 7449132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative determination of valproic acid and 14 metabolites in serum and urine by gas chromatography/mass spectrometry.
    Fisher E; Wittfoht W; Nau H
    Biomed Chromatogr; 1992; 6(1):24-9. PubMed ID: 1600371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay of myo-inositol in cerebrospinal fluid and plasma by chemical ionization mass spectrometry of the hexaacetate derivative.
    Shetty HU; Holloway HW
    Biol Mass Spectrom; 1994 Jul; 23(7):440-4. PubMed ID: 8068740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling of uremic serum by high-resolution gas chromatography-electron-impact, chemical ionization mass spectrometry.
    Schoots AC; Mikkers FE; Cramers CA; Ringoir S
    J Chromatogr; 1979 Sep; 164(1):1-8. PubMed ID: 541389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-inflammatory action of myoinositol in renal insufficiency].
    Rysz J; Bartnicki P; Błaszczak R; Kujawski K; Ciałkowska-Rysz A; Olszewski R; Markuszewski L
    Pol Merkur Lekarski; 2006 Feb; 20(116):180-3. PubMed ID: 16708635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.